Research Progress in the Pathogenesis of Alzheimer's Disease
- PMID: 29941717
- PMCID: PMC6032682
- DOI: 10.4103/0366-6999.235112
Research Progress in the Pathogenesis of Alzheimer's Disease
Abstract
Objective: Alzheimer's disease (AD) is a kind of chronic degenerative disease of the central nervous system, characteristics of cognitive dysfunction, and behavioral disability. The pathological changes include the formation of senile plaques-containing beta-amyloid (Aβ), neurofibrillary tangles (NFTs), loss of neurons, and synapses. So far, the pathogenesis of AD is still unclear. This study was aimed to review the major pathogenesis of AD-related to the published AD studies in recent 20 years.
Data sources: The author retrieved information from the PubMed database up to January 2018, using various search terms and their combinations, including AD, Aβ, NFTs, pathogenesis, and genetic mutation.
Study selection: The author included data from peer-reviewed journals printed in English and Chinese on pathophysiological factors in AD. He organized these informations to explain the possible pathogenesis in AD.
Results: There are many amounts of data supporting the view that AD pathogenesis so far there mainly are Aβ toxicity, tau protein, gene mutation, synaptic damages, intermediate neurons and network abnormalities, changes in mitochondrial function, chemokines, etc., Its nosogenesis may be involved in multiple theories and involved in multiple molecular signaling pathways, including Aβ, tau protein, and synaptic anomaly; mutual relationship between the mechanisms urge jointly neuronal degeneration.
Conclusions: This review highlights the research advances in the pathogenesis of AD. Future research has needed to fully disclose the association between multiple pathogenesis at the same time to interdict multiple signaling pathways, etc.
阿尔茨海默病机制的研究进展摘要目的:阿尔茨海默病(AD)是一种慢性中枢神经系统的退行性疾病, 其特征是认知障碍和行为无能。其病理改变包括:老年斑的形成、神经原纤维缠结、神经元和突触丧失等。至今AD的发生机制仍不很清楚。该文旨在对近20年已发表的有关AD主要发生机制的研究做一综述。 资料来源:本人通过PubMed等数据库检索了截止到2018年1月的大量信息, 使用了各种检索词和其组合如AD、Aβ、神经原纤维缠结、发生机制和基因突变等。 资料选择:本人列入了许多来源于以中、英文发表于同行评议杂志上的有关AD病理生理因素的资料。 结果:许多资料表明, 迄今为止AD的发生主要与Aβ毒性、tau蛋白、基因突变、突触损伤等有关。AD的发生机制可能涉及多种理论, 包含了多条分子信号通路如Aβ、tau蛋白和突触异常等; 这些机制的相互作用共同促进了神经元的退变。 结论:该综述强调了近年来有关AD发生机制的研究进展。未来的研究应该在阻断多条信号通路的同时充分揭示AD多种发生机制间关系。.
Keywords: Alzheimer's Disease; Beta-Amyloid; Neurofibrillary Tangles; Pathogenesis.
Conflict of interest statement
There are no conflicts of interest
Similar articles
-
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.J Alzheimers Dis. 2021;84(4):1391-1414. doi: 10.3233/JAD-215139. J Alzheimers Dis. 2021. PMID: 34719499 Review.
-
Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.Mol Cells. 2017 Sep 30;40(9):613-620. doi: 10.14348/molcells.2017.0096. Epub 2017 Sep 20. Mol Cells. 2017. PMID: 28927263 Free PMC article. Review.
-
[Involvement of beta-amyloid in the etiology of Alzheimer's disease].Brain Nerve. 2010 Jul;62(7):691-9. Brain Nerve. 2010. PMID: 20675873 Review. Japanese.
-
Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease.J Pharmacol Sci. 2012;118(3):331-7. doi: 10.1254/jphs.11r10fm. Epub 2012 Mar 2. J Pharmacol Sci. 2012. PMID: 22382659 Review.
-
[Alzheimer disease: cellular and molecular aspects].Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. Bull Mem Acad R Med Belg. 2005. PMID: 16768248 French.
Cited by
-
Protective Effect of Buyang Huanwu Decoction on Neurovascular Unit in Alzheimer's Disease Cell Model via Inflammation and RAGE/LRP1 Pathway.Med Sci Monit. 2019 Oct 18;25:7813-7825. doi: 10.12659/MSM.917020. Med Sci Monit. 2019. PMID: 31625533 Free PMC article.
-
Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: a nucleoside with multitarget brain actions.Psychopharmacology (Berl). 2020 Mar;237(3):811-823. doi: 10.1007/s00213-019-05419-5. Epub 2019 Dec 13. Psychopharmacology (Berl). 2020. PMID: 31834453
-
Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review).Int J Mol Med. 2023 Nov;52(5):111. doi: 10.3892/ijmm.2023.5314. Epub 2023 Oct 6. Int J Mol Med. 2023. PMID: 37800614 Free PMC article. Review.
-
Potential Anti-Cholinesterase Activity of Bioactive Compounds Extracted from Cassia grandis L.f. and Cassia timoriensis DC.Plants (Basel). 2023 Jan 11;12(2):344. doi: 10.3390/plants12020344. Plants (Basel). 2023. PMID: 36679057 Free PMC article.
-
Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.Alzheimers Dement. 2019 Jun;15(6):788-798. doi: 10.1016/j.jalz.2019.01.011. Epub 2019 Mar 29. Alzheimers Dement. 2019. PMID: 30935898 Free PMC article.
References
-
- Lendon CL, Ashall F, Goate AM. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA. 1997;277:825–31. doi: 10.1001/jama.1997.03540340059034. - PubMed
-
- Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SH, Riehle C, et al. Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry. 2010;15:756–66. doi: 10.1038/mp.2008.141. - PubMed
-
- Chesler EJ, Lu L, Shou S, Qu Y, Gu J, Wang J, et al. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet. 2005;37:233–42. doi: 10.1038/ng1518. - PubMed
-
- Chou PS, Wu MN, Chou MC, Chien I, Yang YH. Angiotensin-converting enzyme insertion/deletion polymorphism and the longitudinal progression of Alzheimer's disease. Geriatr Gerontol Int. 2017;17:1544–50. doi: 10.1111/ggi.12929. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical